Benzinga | Apr 8, 2021 06:31AM EDT

Magellan Health's Magellan Rx Management and Trapelo Health to Offer Precision Oncology Platform for Next-Generation Care

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ:MGLN), and Trapelo Health, today announced that they are collaborating to champion a more comprehensive, integrated approach to value-based care in the new era of precision oncology treatments.

The collaboration combines the unique strengths of the two organizations: Magellan Rx's comprehensive oncology management solution, and the Trapelo(r) precision-medicine platform that enables fast, precise test and treatment decision support, including test order management, results interpretation and streamlined prior authorizations.